The group's principle activity is to provide preclinical assessments and evaluation of anti-cancer and anti-inflammatory therapeutic agents. The group’s additional services include preclinical efficacy testing, non-invasive imaging, pharmacodynamics, pharmacokinetics, in vitro testing and consulting. The group operates from United States.
